Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000227045 | SCV000287520 | benign | Colorectal cancer, susceptibility to, 10 | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000759934 | SCV000521725 | likely benign | not provided | 2021-05-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000572062 | SCV000670973 | likely benign | Hereditary cancer-predisposing syndrome | 2018-11-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Counsyl | RCV000227045 | SCV000785759 | likely benign | Colorectal cancer, susceptibility to, 10 | 2017-11-24 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000759934 | SCV000889647 | benign | not provided | 2019-03-29 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000572062 | SCV002534584 | benign | Hereditary cancer-predisposing syndrome | 2020-12-31 | criteria provided, single submitter | curation | |
KCCC/NGS Laboratory, |
RCV000227045 | SCV004016655 | benign | Colorectal cancer, susceptibility to, 10 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000227045 | SCV004018525 | uncertain significance | Colorectal cancer, susceptibility to, 10 | 2023-04-19 | criteria provided, single submitter | clinical testing | This variant is classified as a variant of uncertain significance as there is insufficient evidence to determine its impact on protein function and/or cancer risk. |
Center for Genomic Medicine, |
RCV003493538 | SCV004242983 | likely benign | not specified | 2024-02-06 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004541393 | SCV004780529 | likely benign | POLD1-related disorder | 2019-02-18 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |